These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 22306098)
21. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital. Novak A; Spigaglia P; Barbanti F; Goic-Barisic I; Tonkic M Anaerobe; 2014 Dec; 30():18-23. PubMed ID: 25079669 [TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain. Secco DA; Balassiano IT; Boente RF; Miranda KR; Brazier J; Hall V; dos Santos-Filho J; Lobo LA; Nouér SA; Domingues RM Anaerobe; 2014 Aug; 28():85-9. PubMed ID: 24907488 [TBL] [Abstract][Full Text] [Related]
23. Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment. Tian TT; Zhao JH; Yang J; Qiang CX; Li ZR; Chen J; Xu KY; Ciu QQ; Li RX PLoS One; 2016; 11(3):e0151964. PubMed ID: 27011211 [TBL] [Abstract][Full Text] [Related]
24. Inappropriate use of antibiotics and Clostridium difficile infection. Srigley JA; Brooks A; Sung M; Yamamura D; Haider S; Mertz D Am J Infect Control; 2013 Nov; 41(11):1116-8. PubMed ID: 23932828 [TBL] [Abstract][Full Text] [Related]
25. What is hot in the anaerobe literature? Clostridium difficile infections. Nord CE Anaerobe; 2013 Dec; 24():107-8. PubMed ID: 23587754 [No Abstract] [Full Text] [Related]
27. Antimicrobial resistance of Clostridium difficile isolates in a tertiary medical center, Israel. Bishara J; Bloch Y; Garty M; Behor J; Samra Z Diagn Microbiol Infect Dis; 2006 Feb; 54(2):141-4. PubMed ID: 16406180 [TBL] [Abstract][Full Text] [Related]
28. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates. Russello G; Russo A; Sisto F; Scaltrito MM; Farina C New Microbiol; 2012 Jul; 35(3):307-16. PubMed ID: 22842600 [TBL] [Abstract][Full Text] [Related]
29. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain. Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance patterns and PCR-ribotyping of Clostridium difficile strains isolated from swine and dogs in Italy. Spigaglia P; Drigo I; Barbanti F; Mastrantonio P; Bano L; Bacchin C; Puiatti C; Tonon E; Berto G; Agnoletti F Anaerobe; 2015 Feb; 31():42-6. PubMed ID: 25316022 [TBL] [Abstract][Full Text] [Related]
31. Collateral damage. The rise of resistant C. difficile. Taubes G Science; 2008 Jul; 321(5887):360. PubMed ID: 18635789 [No Abstract] [Full Text] [Related]
32. Extended spectrum beta-lactamase-producing bacteria and Clostridium difficile in patients with pouchitis. McLaughlin SD; Clark SK; Roberts CH; Perry-Woodford ZL; Tekkis PP; Ciclitira PJ; Nicholls RJ Aliment Pharmacol Ther; 2010 Sep; 32(5):664-9. PubMed ID: 20626734 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of antimicrobial resistance and association with toxin genes in Clostridium difficile in commercial swine. Thakur S; Putnam M; Fry PR; Abley M; Gebreyes WA Am J Vet Res; 2010 Oct; 71(10):1189-94. PubMed ID: 20919905 [TBL] [Abstract][Full Text] [Related]
35. [Practical experience with the detection Clostridium difficile]. Chmelarová E; Skapová T Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):86-9. PubMed ID: 20640985 [TBL] [Abstract][Full Text] [Related]
36. Clostridium septicum aortitis: Report of two cases and review of the literature. Seder CW; Kramer M; Long G; Uzieblo MR; Shanley CJ; Bove P J Vasc Surg; 2009 May; 49(5):1304-9. PubMed ID: 19307090 [TBL] [Abstract][Full Text] [Related]
37. Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection. Kundrapu S; Sunkesula VC; Jury LA; Sethi AK; Donskey CJ Clin Infect Dis; 2012 Dec; 55(11):1527-30. PubMed ID: 22911648 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model. Baines SD; Chilton CH; Crowther GS; Todhunter SL; Freeman J; Wilcox MH J Antimicrob Chemother; 2013 Aug; 68(8):1842-9. PubMed ID: 23557928 [TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of fidaxomicin for Clostridium difficile treatment. Simon MS Clin Infect Dis; 2014 Feb; 58(4):603. PubMed ID: 24300043 [No Abstract] [Full Text] [Related]
40. Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections. Million M; Hocquart M; Seghboyan JM; Griffiths K; Halfon P; Lagier JC; Brouqui P; Raoult D Int J Antimicrob Agents; 2015 Aug; 46(2):227-8. PubMed ID: 26092095 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]